| Authors: |
Rutherford SC; Weill Cornell Medicine, New York, NY., Li H; Fred Hutchinson Cancer Center, Seattle, WA., Herrera AF; City of Hope Comprehensive Cancer Center, Duarte, CA., LeBlanc M; Fred Hutchinson Cancer Center, Seattle, WA., Ahmed S; The University of Texas MD Anderson Cancer Center, Houston, TX., Davison K; Royal Victoria Hospital, McGill University Health Centre, Montreal, QC, Canada., Parsons SK; Tufts Medical Center, Boston, MA., Unger JM; Fred Hutchinson Cancer Center, Seattle, WA., Perry AM; University of Michigan, Ann Arbor, MI., Casulo C; Wilmot Cancer Center, University of Rochester, Rochester, NY., Bartlett NL; Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO., Tuscano JM; University of California, Davis Medical Center, Sacramento, CA., Hess BT; Medical University of South Carolina, Charleston, SC., Torka P; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Kumar P; Illinois CancerCare, Bloomington, IL., Jacobs R; Atrium Health Levine Cancer Institute, Charlotte, NC., Song JY; City of Hope Comprehensive Cancer Center, Duarte, CA., Castellino SM; Department of Pediatrics, Emory University School of Medicine, Aflac Cancer and Blood Disorders Center, Atlanta, GA., Kahl B; Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO., Leonard JP; Weill Cornell Medicine, New York, NY., Smith SM; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL., Friedberg JW; Wilmot Cancer Center, University of Rochester, Rochester, NY., Evens AM; Division of Blood Disorders, Rutgers Cancer Institute New Jersey, New Brunswick, NJ. |
